Asianet NewsableAsianet Newsable

Sputnik V COVID vaccine production in India to begin by August, 3 million doses to be supplied by May-end

The production of the Sputnik Covid-19 vaccine in India is expected to start in August, said Indian envoy to Russia, Bala Venkatesh Varma, adding that Russia has supplied over 2 lakh doses of the vaccine to India.

Sputnik V COVID vaccine production in India to begin by August, 3 million doses to be supplied by May-end-dnm
Author
New Delhi, First Published May 22, 2021, 1:45 PM IST

In a development that could potentially boost India's vaccination campaign, Sputnik V's local production is expected to start by August, said Indian envoy to Russia Bala Venkatesh Varma on Saturday.

Varma asserted that three million doses of the vaccine will be supplied in bulk by May-end and the number is expected to increase to five million by June. As per the present plan, more than 850 million doses of the Sputnik V will be produced in India, he said further.

"For Sputnik, 1,50,000 doses plus 60,000 doses have been already supplied to India. By May-end, about 3 million more doses will be supplied in bulk. Those will be filled in India. In June, the supply is expected to increase to 5 million and production in India expected to start in August," said Varma.

According to Dr Verma Sputnik V will be available in India in three ways — fully made vaccines supplied from Russia, ready to use vials to be filled in India, and vaccines produced by Indian partners using the technology transferred by Russia.

The fill and finish mode refers to the vials being filled with the vaccine in India.

This could be a major step towards India’s vaccination campaign for all above 18 years as several states are facing vaccine crunch.

In August 2020, Russia became the world’s first country to register a coronavirus vaccine, Sputnik V. Subsequently, in September, Dr Reddy’s and (RDIF entered into a partnership to conduct clinical trials of Sputnik V, which is developed by the Gamaleya National Research Institute of Epidemiology and Microbiology.

Dr Reddy’s Laboratories has received approval from the Indian drug regulator for restricted emergency use of Sputnik V. RDIF has tied up with six Indian drug makers to manufacture Sputnik V.

NOTE: Asianet News humbly requests everyone to wear masks, sanitize, maintain social distancing and get vaccinated as soon as eligible. Together we can and will break the chain #ANCares #IndiaFightsCorona 

Follow Us:
Download App:
  • android
  • ios